In conclusion, our study reveals a new mechanism of curcumin against hepatocellular carcinoma and identifies the core target of curcumin-mediated ferroptosis, ACSL4, which provides a broader scientific explanation for the clinical application of curcumin. This evidence concerns the gene ACSL4 and hepatocellular carcinoma.